Consultant Clinical Scientist. Ronald Finn Senior Research Fellow. Honorary Senior Lecturer. Clinical Biochemistry/Metabolomics/Mass Spectrometry Enthusiast.
NIHR CRF: Liverpool leads a new Phase I ulcerative colitis study, ahead of sites in the US & Europe.
Delivered in just 118 days, a huge team effort bringing research to patients sooner 👏
🔗https://t.co/mfUGvCGXv8
🔬One month left to apply for the two research grants are available from North West Cancer Research. Do you have an idea to support innovative cancer research in the UK?
Find out more and apply here: https://t.co/ii8DRk7QMi
#CancerResearch#ResearchFunding#ChildhoodCancer
Run for research and take part in the world's biggest half marathon with 57,000 other determined and dedicated runners 🏃♀️➡️
📅Date: 13th September 2026
🎟️Registration: £40
💛Minimum Sponsorship: £350
Sign up today: https://t.co/Zc6oXfxyCC
@Hapangama_Lab We also interviewed the first author Muhammad Dimas Reza Rahmana
"We believe that publishing in DMM will attract more readers from various backgrounds who are interested in disease modelling and stimulate further research in this field"
https://t.co/jOoMcd4UjO
Due to its vague presentation, diagnosis of #Addison's disease is often delayed, and in some cases, individuals present in adrenal crisis https://t.co/yw7PrItFCr
#adrenal#insufficiency
Our Innovation Team at University Hospitals of Liverpool Group (UHLG) has launched the Innovator’s Forum for staff - a new platform designed to drive forward healthcare innovation.
From frontline ideas to transformative technologies, we’re supporting staff to improve care and shape the future of healthcare.
🔹 Empowering clinical innovation
🔹 Supporting staff-led solutions
🔹 Enhancing patient outcomes
Explore how innovation is embedded in everything we do: https://t.co/acZQ0fbmkR
#Innovation #NHS #LiverpoolHospitals #FutureOfHealthcare #UHLG
Introduction to Applying LC-MS in Untargeted Metabolomics 3-5 Nov is open for registration. Join us and gain practical-based experience of performing LC-MS metabolomics. Further information available here https://t.co/zMQhUiDEkc @rickdunnblade
Do you want to learn how to apply GC-MS in untargeted metabolomics? Join us @rickdunnblade for our next course - Introduction to Applying GC-MS in Untargeted Metabolomics, 27-29 Oct. Further information is available here https://t.co/8EB7JdxNu1
📣 Now Recruiting into a Clinical Trial for Liver Disease
We’re running a Phase 3 trial testing new treatments for people living with steatohepatitis & liver fibrosis.
👉 Interested in taking part? Call our research team on 0151 529 6620.
#liverhealth#Clinicaltrial#NHS
An exciting fixed term or a secondment development opportunity has arisen for a highly experienced, suitably qualified HCPC registered Specialist Biomedical Scientist to join the Transfusion Laboratories of Blood Sciences at Liverpool Clinical Laboratories.
More information👇
We want to change health outcomes for future generations by learning more about children growing up in Liverpool.
If you’re pregnant and receiving care @LiverpoolWomens ask staff about C-GULL.
You could be eligible to receive vouchers for taking part and proving certain samples.
📢 University Hospitals of Liverpool Group has secured NIHR Strategic Funding to lead pioneering healthcare research across the North West.
From dental care to women’s health and pharmacy, these initiatives will make research more inclusive, accessible, and impactful.
🔗https://t.co/svSKKLxN9e
#NIHR #HealthResearch #Liverpool #InnovationInCare
Our #UHLGKnowledgeGnomes joined the research team at the Research Network Meeting, giving them insight on the delivery of research at our Liverpool Hospitals sites.
The team meet to discuss important updates on clinical trials, upcoming trials and how we can best support patients to take part in research.
#HomeGrownResearch
📌#Adrenal insufficiency: a comprehensive clinical update just published in @JAMA_current.
🧠 Pathophysiology
🔍 Diagnosis (cortisol, ACTH, DHEAS)
💉 Treatment & stress dosing
📊 See key figures below for practical insights
🔗 https://t.co/P7taD5Ilov
#EndoTwitter#MedTwitter
One of our leading researchers, Professor John Wilding, Honorary Consultant in Cardiovascular and Metabolic Medicine at UHLG, spoke to BBC Breakfast last week about the research happening in weight-loss medication.